Tzar Labs

📍 Singapore, Singapore👥 3 employees💰 Last funded Nov 2019
Biotechnology Research🌐 linktr.ee
Website LinkedIn
Tzar Labs is in the business of development of cancer prognostic and diagnostic technologies, and specializes in discovering, building and commercializing innovative tests that can contribute to a clinically meaningful difference in the detection and management of cancer. The Company has developed a first-of-its-kind non-invasive 'HrC' test (NIHT) which is the most accurate screening test for all cancer and can distinguish between non-cancer, imminent cancer and the different stages of cancer. It is also the first prognostic test for cancer. The company has a host of prestigious investors from the USA, Europe and Asia.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Tzar Labs?
Tzar Labs has 1 investors on record on gritt.io.
When did Tzar Labs last raise funding?
The most recent investment in Tzar Labs recorded on gritt.io was in November 2019.
What industry is Tzar Labs in?
Tzar Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tzar Labs based?
Tzar Labs is headquartered in Singapore, Singapore.